Pharmaceutical R&D Market Valued at $183.62 Bn
The market for pharmaceutical R&D expanded significantly in 2021, its valuation increasing to $183.62 Bn. The US is currently the largest market for pharmaceutical R&D in the world and accounts for almost half of spend. In recent years costs in the R&D market have risen thanks to factors such as greater technological complexity and greater specificity in disease targets. However, small firms tend to receive access to knowledge and resources that are designed to help ensure a more equal playing...
View full press release